Chairman’s investor briefing on Next Science - March 2019
With the opening of Next Science’s IPO today, Chairman George Savvides discusses the company’s business strength and fundamentals.
CEO’s investor briefing on Next Science - March 2019
CEO Judith Mitchell talks about Next Science’s medical technology platform that’s already helped 70,000 patients with chronic wound infections as well as the company’s long-term plans for growth.
Next Science’s Chief Technology Officer explains breakthrough technology combatting chronic infections - March 2019
Founder and Chief Technology Officer Dr Matthew Myntti outlines the robust science behind the company’s Xbio-based products that destroy, treat and protect people against biofilm-shielded bacterial infections.